In an early study, Petrovics et al (2005) found that ERG sequences were overexpressed in prostate cancer cells relative to adjacent benign prostate cells (at a level of twofold or greater) in approximately 80% of prostate cancers. This evidence concerns the gene ERG and prostate cancer.